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Abstract
Background: Klebsiella pneumoniae is a prominent nosocomial pathogen that accounts for up to 10 % of all
hospital-acquired infections. It is a frequent cause of ventilator-associated pneumonia (VAP). The purpose of this
study was to investigate the clinical characteristics of K. pneumoniae-associated VAP and the molecular
characteristics of K. pneumoniae strains.
Methods: We retrospectively reviewed 70 mechanically ventilated patients with K. pneumoniae isolated. All K.
pneumoniae strains were examined to determine hypermucoviscosity (HV) phenotype, capsular serotypes, virulence
genes, multilocus sequence typing and antimicrobial susceptibility.
Results: Hypermucoviscosity was found in 14 of 70 (20 %) isolates of K. pneumoniae. Among the 70 patients, 43
cases (61.4 %) developed VAP. Furthermore, VAP was more frequently induced by HV-positive K. pneumoniae (14/14,
100 %) than by HV-negative strains (29/56, 51.7 %). HV-positive K. pneumoniae-associated VAP patients were more
inclined to develop bacteremia and had a higher mortality rate than HV-negative strains VAP patients. Antibiotic
resistance was more frequent in HV- negative strains- than in HV- positive strains-infected patients. The prevalence
of rmpA and aerobactin genes were 85.7 % and 85.7 % respectively, and serotypes K1 and K2 accounted for 14.3 %
and 28.6 % of the hypermucoviscosity strains, respectively. Strains carrying rmpA and aerobactin genes were
significantly associated with HV-phenotype, and rmpA and aerobactin coexisted in HV-positive strains. Multilocus
sequence typing analysis identified 24 different sequence types from K. pneumoniae VAP samples.
Conclusions: HV-phenotype is the major virulence determinant for mechanically ventilated patients. There was a
specific sequence typing (ST) distribution between HV-positive and HV-negative strains.
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Background
Ventilator-associated pneumonia (VAP) is defined as
nosocomial pneumonia occurring in a patient after 48 h
of mechanical ventilation. The occurrence rate of VAP is
reportedly 9–27 %, and mortality reaches 20–50 %
[1–3]. Common causative pathogens of VAP include
gram-negative bacteria such as Pseudomonas aeruginosa,
Klebsiella pneumoniae, and Escherichia coli and gram-
positive bacteria such as Staphylococcus aureus [4–9].
K. pneumoniae is a common pathogen responsible for
both community-acquired and nosocomial infections
[10]. It also causes miscellaneous infections such as
meningitis, septicemia, purulent abscesses, and pneumo-
nia. Previous investigations have implicated K. pneumo-
niae in 7–12 % of nosocomial pneumonia in intensive
care units in the United States [11, 12].
It has been reported that the HV-positive phenotype,
certain serotypes, and the presence of rmpA and aero-
bactin genes are virulence determinants in K. pneumo-
niae infection [13–17]. However, there have been few
reports on the specific roles of these factors in VAP in
mainland China. In the present study, we used isolates
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collected from mechanically ventilated patients to delin-
eate the clinical characteristics of K. pneumoniae-associ-
ated VAP and molecular characteristics of K.
pneumoniae strains observed over a 2-year period.
Methods
Hospital setting and study population
The Henan Provincial People’s Hospital is a 3900 bed
tertiary care hospital with 6 ICU wards with an approxi-
mate annual admission of 1600 ICU inpatients. K. pneu-
moniae strains were collected via endotracheal
aspiration from mechanically ventilated patients with
suspected pneumonia and stored at −80 °C before use.
Medical records of patients from whom the collected
strains were isolated were reviewed between January
2012 and August 2014. VAP was diagnosed in these pa-
tients who fulfilled both the clinical and microbiological
criteria. The clinical criteria for the diagnosis of VAP are
the presence of a new pulmonary infiltration on chest
radiography plus at least two of the following: fever
above 38 °C, purulent secretions, and leukocytosis or
leucopenia [18]. The microbiological criteria are quanti-
tative tracheal aspirate culture with ≥105 CFU/mL and
positive gram stain (>10 polymorphonuclear cells/low-
power field and ≥1 bacteria/oil immersion field with or
without intracellular bacteria) [19–21]. The VAP diagno-
sis was reconfirmed by two infectious diseases specialists
independently. Polymicrobial infections were excluded
from the analysis.
Data collection and microbiologic analysis
The following clinical information was collected for each
patient: demographic characteristics, VAP diagnosis, rea-
sons for mechanical ventilation, laboratory data, and
chest radiograph reports. Bacteremic VAP was diagnosed
when blood and respiratory samples yielded the same
microorganism and other sources of infection that could
account for the bacteremia were absent. Furthermore,
blood and respiratory cultures were performed within
48 h.
Outcome was defined as in-hospital mortality mea-
sured 30 days after the onset of VAP. Trauma was
defined as the presence of injury in more than one body
area or system or the presence of major cranial trauma
alone. Chronic lung diseases included bronchiectasis,
chronic obstructive pulmonary disease. The initial la-
boratory value was defined as that measured within 48 h
of the onset of VAP.
The BD Phoenix system (Becton Dickinson, USA) was
used to confirm bacterial identification. Antibiotic sus-
ceptibility was tested with the disk diffusion method,
and interpretations were made according to the guide-
lines of the Clinical and Laboratory Standards Institute
[22]. All of the K. pneumoniae isolates were screened
and confirmed by a double-disk synergy test for pro-
duced extended-spectrum β-lactamase (ESBL).
Detection of HV-phenotype
For HV-phenotype determination, a standard bacterio-
logic loop was used to stretch a mucoviscous string ver-
tically from a colony. The formation of a viscous string
of >5 mm confirmed the HV-positive phenotype.
Serotyping, rmpA and aerobactin gene detection with
PCR
PCR was performed to amplify genes specific for sero-
types K1/K2 and the rmpA and aerobactin genes as de-
scribed previously [17, 23]. K. pneumoniae ATCC9997
(K2) was used as a control strain. A bacterial colony
from an overnight culture was added to 500 μL water
and boiled for 15 min to release the DNA template. PCR
was performed with the following conditions: 95 °C ini-
tial denaturation for 5 min followed by 30 cycles at 95 °
C for 30 s, 55 °C for 30 s, 72 °C for 90 s, and a final ex-
tension at 72 °C for 5 min.
Multilocus sequence typing (MLST)
MLST was performed to determine the diversity of clin-
ical K. pneumoniae in patients with VAP. Seven house-
keeping genes (rpoB, gapA, mdh, pgi, phoE, infB, and
tonB) were amplified via PCR with conditions and
primers designated by the Pasteur Institute Klebsiella
pneumonia MLST Database (http://bigsdb.pasteur.fr/
klebsiella/klebsiella.html).
Statistical analysis
SPSS 17.0 was used for statistical analysis. The chi-
square or Fisher’s exact test was used to analyze contin-
gency data, and continuous data were analyzed with the
Student’s t test. A P value of <0.05 was considered sig-
nificant, and all probabilities were two-tailed.
Results
Clinical characteristics of K. pneumoniae-associated VAP
patients
The retrospective study was conducted in 70 mechanic-
ally ventilated patients with K. pneumoniae isolated.
Among these patients, 43 cases (61.4 %) developed VAP
during their ICU stay. The patients had mean ± standard
deviation age of 57.0 ± 15.0 years. Thirty-two (74.4 %)
were male and 11(25.6 %) were female. Fourteen
(32.5 %) HV-positive strains and 29 (67.4 %) HV-
negative strains were isolated from the 43 VAP patients.
None of the VAP patients had concurrent live abscess or
other metastatic infection. All VAP patients received
concordant antibiotic treatment according to the results
of susceptibility testing. The clinical characteristics of
HV-positive and -negative K. pneumoniae VAP patients
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are compared in Table 1. Compared with patients with
HV-negative K. pneumoniae, those with HV-positive
strains had a significantly higher prevalence of cardiac-
cerebrovascular disease (55.1 % vs 85.7 %, respectively,
P = 0.049), a significantly higher prevalence of
bacteremic K. pneumoniae (3.4 % vs 35.7 %, respectively,
P = 0.017) and a significantly higher mortality rate
(57.1 % vs 13.8 %, respectively, P = 0.009). The laboratory
data of the K. pneumoniae VAP patients is presented in
Table 2. Compared with patients with HV-negative K.
pneumoniae, those with HV-positive strains had a sig-
nificantly higher C-reactive protein (CRP) levels (100.16
± 77.62 vs 156 ± 53.89, respectively, P = 0.03), lower albu-
min levels (34.007 ± 6.49 vs 29.68 ± 5.31, respectively, P
= 0.038).
Microbiological characteristics of K. pneumoniae
Among 70 K. pneumoniae isolates analyzed, 14 (20 %) of
them were found to be HV-positive strains and 56
(80 %) of them were HV-negative strains. We further
observed that the frequency of VAP was significantly
higher in patients with HV-positive strains (100 %;
14/14) than in patients with HV-negative strains (51.8 %;
29/56). The results showed that HV-phenotype was
highly correlated with the presence of the rmpA and
aerobactin genes. Of 14 HV-positive isolates, 85.7 %
(12/14) were rmpA and aerobactin positive, and 14.3 %
(2/14) were rmpA and aerobactin negative. None of
HV-negative isolates was rmpA or aerobactin positive.
Serotypes K1 and K2 accounted for 14.3 % (2/14) and
28.6 % (4/14), respectively, of the HV-positive isolates. Se-
rotypes K1 and K2 were not found among HV-negative
isolates. All 12 rmpA-positive isolates carried the aerobac-
tin gene. All K1/K2 isolates (n = 6) were positive for HV-
phenotype and the rmpA and aerobactin genes (Table 3).
Antimicrobial susceptibility test
The prevalence of HV-negative isolates exhibiting
resistance to the tested antimicrobials was higher than
that of the HV-positive isolates (Table 4). The detection
rates of ESBL-producing K. pneumoniae isolates were
46.5 % (20/43). The percentage of ESBL-producing
HV-negative isolates was significantly higher than that of
ESBL-producing HV-positive isolates (62.1 % compared
to 14.3 %, P < 0.05). Among all of the isolates, one of
them (1/43, 2.3 %) was resistant to imipenem and
meropenem.
Table 1 Relationship between hypermucoviscosity phenotype
of K. pneumoniae and clinical characteristics
Hypermucoviscosity
Characteristic Positive Negative P value
n = 14 n = 29
No. (%) No. (%)
Age mean ± SD 64 ± 14 53 ± 15 0.613
Male sex 11 (78.6) 21 (72.4) 0.665
Underlying disease
Diabetes mellitus 3 (21.4) 2 (6.8) 0.376
Malignancy 1 (7.1) 1 (3.4) 1.000
Neurologic disorders 6 (42.9) 13 (44.8) 0.903
Trauma 1 (7.1) 5 (17.2) 0.670
Chronic lung disease 1 (7.1) 1 (3.4) 1.000
Cardiac-cerebrovascular disease 12 (85.7) 16 (55.1) 0.049*
ICU stay, days 14 ± 6 13 ± 5 0.452
Mechanical ventilation, days 8 ± 4 6 ± 3 0.141
Bacteremia 5(35.7) 1 (3.4) 0.017*
Mortality 8 (57.1) 4 (13.8) 0.009*
Values given as means ± SD or No. (%) of patients
*P < 0.05 was considered to be statistically significant
Table 2 Relationship between hypermucoviscosity phenotype
of K. pneumoniae and laboratory data
Hypermucoviscosity
Characteristic Positive Negative P value
n = 14 n = 29
No. (%) No. (%)
Chest radiography
Unilateral involvement 3 (21.7) 6 (20.6) 1.000
Bilateral involvement 11 (78.6) 23 (79.3) 1.000
Initial laboratory value
Leukocyte count, ×109/l 14.56 ± 7.21 15.65 ± 6.21 0.613
Platelet, ×109/l 139.71 ± 82.27 192.10 ± 130.13 0.177
Albumin, g/l 29.68 ± 5.31 34.007 ± 6.49 0.038*
C-reactive protein, mg/l 156.79 ± 53.89 100.16 ± 77.62 0.03*
Glucose, mmol/l 9.85 ± 3.92 8.12 ± 2.94 0.115
Values given as No. (%) of patients
*P < 0.05 was considered to be statistically significant







n = 14 n = 56
No. (%) No. (%)
Capsular serotype
K1 2 2 (14.3) 0 (0) 0.038*
K2 4 4 (28.6) 0 (0) 0.001*
Virulence factors
rmpA 12 12 (85.7) 0 (0) <0.001*
aerobactin 12 12 (85.7) 0 (0) <0.001*
VAP due to K.pneumoniae 43 14 (100) 29 (51.7) 0.001*
Values given as No. (%) of patients
*P < 0.05 was considered to be statistically significant
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MLST profiles of isolates from patients with VAP
Fourteen HV-positive strains and 29 HV-negative strains
were isolated from VAP patients. Eleven MLSTs—in-
cluding sequence types (STs) 23, 36, 65, 86, 218, 225,
374, 412, 499, 592, and 660—were identified among the
HV-positive strains. Two major MLST groups, ST218-
like and ST23-like, were obtained based on minimum-
spanning tree analysis (Fig. 1a). Two serotype K1 isolates
belonged to ST23. In addition, three MLSTs—STs 374,
86, and 65—were identified among serotype K2 isolates.
All of the remaining HV-positive strains except STs 225
and 499 were positive for rmpA and aerobactin. On the
contrary, 13 MLSTs—including STs 1, 11, 15, 17, 35, 37,
107, 147, 515, 716, 988, 1269, and 1419—were identified
among HV-negative isolates. Minimum-spanning tree
analysis showed that all of these isolates belonged to two
major MLST groups, ST1419-like and ST515-like
(Fig. 1b). ST11 (n = 7) and ST15 (n = 7) were the preva-
lent STs in HV-negative isolates.
Discussion
In the retrospective study, we analyzed 70 isolates of
K. pneumoniae from mechanically ventilated patients be-
tween January 2012 and August 2014. We observed that
HV-positive strains accounted for 20 % (14/70) K.
pneumoniae isolates. The genotypes of K1, K2, rmpA
and aerobactin were only positive for HV-positive
strains. The medical records showed that 43 strains
accounted for 61.4 % (43/70) induced VAP in mechanic-
ally ventilated patients. There was difference in ST dis-
tribution between HV-positive and HV-negative stains in
VAP patients.
We further observed that the occurrence rate of VAP
was significantly higher for HV-positive strains infection
than HV-negative strains infection (100 % vs 51.7 %, P <
0.05). Furthermore, the results showed that bacteremic
VAP occurred more frequently in HV-positive strains
than in HV-negative strains (35.7 % vs 3.4 %, respect-
ively, P = 0.017). The mortality rate was higher in the
HV-positive group (57.1 %) than in the HV-negative
group (13.8 %). Laboratory data also showed that
HV-positive strains VAP patients had increased frequency
of higher C-reactive protein (CRP) and lower albumin
levels. CRP is an acute-phase protein that has been
evaluated in the critical care setting [24]. Moreover, CRP
values correlated well with the severity of the infection.
Hillas et al. [25] observed that a rise in CRP between days
1 and 7 increases the risk of septic shock. Albumin level
reportedly decreases as part of negative acute-phase
protein. Previous studies have indicated that the degree of
hypoalbuminemia in critically ill patients correlates with
the intensity of the inflammatory response caused by in-
fection [26, 27]. These findings indicated that compared
with HV-negative strains, HV-positive strains are more
virulent in the development of VAP.
Capsular serotypes, especially serotypes K1 and K2,
are important virulence factors for K. pneumoniae
[28, 29]. Yu et al. reported that the capsular serotypes
K1 and K2 have particular virulence and were more
common in patients with community-acquired pneu-
monia (23/49 isolates, 47 %) than in those with
hospital-acquired pneumonia (2/18 isolates, 11 %)
[30]. Our results were similar to the study. We also
found that capsular serotypes K1 and K2 comprised
only 4.7 % (2/43) and 9.3 % (4/43), respectively, of all
K. pneumoniae isolated from VAP patients. In
addition, the HV-positive strains accounted for 32.6 %
(14/43) K. pneumoniae in VAP patients. These results
suggest that hypermucoviscosity rather than serotype
K1 or K2 has become a common pathogen of VAP in
mechanically ventilated patients.
Previous study has shown that K1 serotype and rmpA
are associated with HV-phenotype in K. pneumoniae
[17]. In this study, we found that HV-phenotype fre-
quently coexists with the rmpA gene. In addition, the
prevalence of the K1 serotype in HV-positive strains was
only 14.3 % (2/14). Chen et al. further confirmed that
the rmpA gene is a regulator of HV-phenotype [31]. Loss
of this gene leads to the loss of HV-phenotype. These
Table 4 Difference of the antimicrobial susceptibility between
HV-positive and- negative of K. pneumoniae






n = 14 n = 29
piperacillin 8 (57.1) 9 (31.0) 0.101
Cefazolin 5 (35.7) 10 (34.4) 1.000
Cefoxitin 10 (71.4) 14 (48.3) 0.152
Cefuroxime 11 (78.6) 11(37.9) 0.012*
Ceftriaxone 12 (85.7) 12 (41.4) 0.006*
Ceftazidime 12 (85.7) 12 (41.4) 0.006*
Cefotaxime 12 (85.7) 13 (44.8) 0.011*
Cefepime 13 (92.9) 23 (79.3) 0.492
Imipenem 14 (100) 28 (96.6) 1.000
Meropenem 14 (100) 28 (96.6) 1.000
Ciprofloxacin 12 (85.7) 15 (51.7) 0.031*
Levofloxacin 12 (85.7) 16 (55.2) 0.104
Gentamicin 14 (100) 17(58.6) 0.013*
Amikacin 14 (100) 18 (62.1) 0.022*
Trimethoprim-
sulfamethoxazole
12 (85.7) 17 (58.6) 0.013*
ESBLs 2 (14.3) 18 (62.1) 0.003*
Values given as No. (%) of patients
ESBL, extended-spectrum β-lactamase
*P < 0.05 was considered to be statistically significant
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data showed that the rmpA gene rather than the K1
serotype correlated with HV-phenotype in K. pneumo-
niae. Meanwhile, the results also showed that two
HV-positive strains which did not possessed rmpA gene.
This indicated that there may be other regulatory mech-
anisms for expression of HV-phenotype.
In addition, we found that rmpA gene coexists with
the aerobactin gene in HV-positive K. pneumoniae.
This result was in line with the observations of Yu et
al. [30]. Further investigation showed that rmpA is
located on a 180-kb virulence plasmid, which also
contains many virulence-associated genes, including
aerobactin for iron acquisition [15, 32]. However, we
did not determine which of the two virulence factors
(rmpA or aerobactin) of HV-positive strains is more
critical in VAP.
Among these VAP patients, the HV-positive isolates
were significantly more susceptible to the antimicrobial
agents that were tested, when compared with the
HV-negative isolates. However, we found two ESBL-
producing HV-positive isolates. Previous study also
showed that most HV-positive strains were very suscep-
tible to antimicrobials [33]. Nonetheless, some cases of
infection due to multidrug resistant HV-positive K.
pneumoniae have already been described [34]. Therefore,
management of VAP due to HV-positive isolates will be-
come extremely challenging.
In the present study, 24 STs were observed in the 43K.
pneumoniae isolates from VAP patients. Eleven MLSTs
were identified in 14 HV-positive strains, suggesting a poly-
clonal origin. Thirteen STs were observed in 29 HV-nega-
tive strains, among which ST11 (n = 7) and ST15 (n = 7)
were the most prevalent. We noticed that a specific ST
distribution occurred between HV-positive and HV-
negative strains, suggesting the difference genetic back-
ground existed among the 2 phenotype isolates.
Fig. 1 Minimum-spanning tree of 14 isolates of hypermucoviscosity-positive strains (a) and 29 hypermucoviscosity-negative strains (b) generated
with multilocus sequence typing (MLST) allelic data (analysis at MLST website)
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This study had several limitations. First, it was a retrospect-
ive study from a single hospital and the small sample size
may have had selection bias. Second, the diagnosis of VAP in
mechanically ventilated patients is difficult, and still there is
no “gold-standard” diagnostic method. Third, the pathogenic
mechanism of HV-positive K. pneumoniae in VAP is unclear
and requires further investigation in future studies.
Conclusion
We have shown that HV-phenotype, rather than serotype
K1 or K2, was the major virulence determinant for mech-
anically ventilated patients. Patients infected with HV-
positive strains were more likely to develop VAP and
bacteremic VAP. Furthermore, HV-positive K. pneumo-
niae VAP had a higher mortality than HV-negative strains
VAP. We hope our results will draw attention from physi-
cians, which may lead to prompt recognition and success-
ful management of HV-positive K. pneumoniaeVAP.
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